Locations:
Search
Tom Mihaljevic, M.D., Cleveland Clinic CEO and President, will welcome Arvind Krishna, Ph.D., Chairman and CEO of IBM, to join him as part of the speaker series, Ideas for Tomorrow.
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/16d18520-f8de-4512-9ae7-0a95a4f5def4/Arvind-Krishna_Approved-Photo_jpg)
Arvind Krishna, Ph.D., Chairman and CEO of IBM
The in-person event will take place from 5:30-6:30 p.m. EDT on Tuesday, June 21, at the InterContinental Hotel, 9801 Carnegie Ave.
Click here to register for this free forum.
As a business leader and technologist, Dr. Krishna has led the building and expansion of new markets for IBM in artificial intelligence, cloud, quantum computing and block chain. He also has played a significant role in the development of innovative IBM products and solutions based on these technologies.
Over his 30-year career at IBM, Dr. Krishna led a series of transformations. He most recently drove the successful $34 billion acquisition of software company Red Hat. Previously, Dr. Krishna was senior vice president of Cloud and Cognitive Software, where he pioneered the company’s hybrid cloud business. He also headed IBM Research, where he led innovation in core and emerging technologies.
Last spring, Cleveland Clinic and IBM announced a 10-year partnership — called the Discovery Accelerator — to bring quantum computing into healthcare for the first time. The joint center has a mission of advancing the pace of discovery in healthcare and life sciences through the use of high-performance computing on the hybrid cloud, artificial intelligence and quantum computing technologies. As part of the collaboration, IBM plans to install its first private sector, on-premises Quantum System One in the U.S., on Cleveland Clinic’s main campus.
Plans also include education and workforce development opportunities related to high-performance computing. The Discovery Accelerator will enhance research in Cleveland Clinic’s Global Center for Pathogen & Human Health Research, announced last year as part of the Cleveland Innovation District.
** Limited seating in the amphitheater will be available on a first-come, first-served basis. Overflow seating will be available when the amphitheater capacity has been reached. The live event also will be live-streamed via Cleveland Clinic Facebook Live.
